Background: Cancer is the second most common cause of death worldwide, killing more than 8 million people every year. The primary treatment is still restricted to conventional chemotherapy; however, this method has some limitations. Drug delivery systems (DDSs) provide the possibility to overcome these defects. Objective: The main object of the present report is to introduce the first amphiphilic macromolecule deduced from vegetable oil as a stimulus-responsive drug delivery system. objective: The main object of this research is to introduce the first amphiphilic macromolecule deduced from vegetable oil as a stimuli-responsive drug delivery system. Methods: Initially, maleated castor oil was synthesized from the reaction of castor oil with 2-hydroxyethyl disulfide. In the last step, a thiol-ene click reaction was carried out under thermal conditions. The structure of the polyol was characterized by proton nuclear magnetic resonance (1HNMR) and Fourier transform infrared spectroscopy (FT-IR). The average size, morphology, CMC, drug loading drug release properties, and cytotoxicity of the nanocarrier were screened by different analyses. Results: The dynamic light scattering and scanning electron microscopy revealed an appropriate size (about 66 nm) and spherical morphology of nanoparticles, respectively. Doxorubicin was encapsulated in polyol with a drug loading efficiency of 83%. in vitro MTT assays confirmed that the micelles are biocompatible and nontoxic, while drug-loaded micelles possess high antitumor activity in cancer cells. Conclusion: Some advantages of this carrier are its uncomplicated synthesis, stimulus responsiveness based on vegetable oil, biocompatibility, good stability, and acceptable critical micelle concentration.
No takes yet. Share an insight, caveat, or question.
Saeedi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: